356. Danny Yeung, CEO of IM8

Today, I'm joined by Danny Yeung, CEO of IM8.

Pivoting from diagnostics, parent company Prenetics has scaled its science-backed supplement brand co-founded with David Beckham to a $400M+ market cap with just two core SKUs.

In this episode, we discuss building IM8 from the ashes of a billion-dollar collapse.

We also cover:

• From billion-dollar IPO to $50M valuation in 18 months
• Simple products, simple messaging
• General Catalyst's revenue-based financing

Subscribe to the podcast → insider.fitt.co/podcast

Subscribe to our newsletter → insider.fitt.co/subscribe

Follow us on LinkedIn → linkedin.com/company/fittinsider

IM8 Website: https://im8health.com/

IM8 on Instagram: https://www.instagram.com/im8health/

The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.

Fitt Talent: https://talent.fitt.co/

Consulting: https://consulting.fitt.co/

Investments: https://capital.fitt.co/

(00:00) Introduction

(01:31) Danny's background

(01:50) Prenetics diagnostics journey

(02:09) COVID testing boom and collapse

(06:03) Meeting David Beckham

(02:09) From $1B to $50M

(08:58) Prenetics to IM8 pivot

(12:28) Organizational strategy

(16:22) Product development approach

(27:58) Retention and data focus

(25:55) Marketing and messaging

(29:39) Scaling challenges

(30:30) General Catalyst financing model

(34:55) Product roadmap

(38:11) Where to follow

(39:35) Conclusion